Click for best price
Targeted Drugs for Colorectal Cancer Market Size, Share 2024
The global Targeted Drugs for Colorectal Cancer market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
EGFR Target Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Targeted Drugs for Colorectal Cancer include Merck, Amgen, F. Hoffmann-La Roche Ltd, Novartis, Array BioPharma, Genentech, Bayer, Sanofi and Lilly, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
This report aims to provide a comprehensive presentation of the global market for Targeted Drugs for Colorectal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Targeted Drugs for Colorectal Cancer. This report contains market size and forecasts of Targeted Drugs for Colorectal Cancer in global, including the following market information:
Global Targeted Drugs for Colorectal Cancer Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Targeted Drugs for Colorectal Cancer Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Targeted Drugs for Colorectal Cancer companies in 2023 (%)
We has surveyed the Targeted Drugs for Colorectal Cancer manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Drugs for Colorectal Cancer Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeted Drugs for Colorectal Cancer Market Segment Percentages, by Type, 2023 (%)
EGFR Target
BRAF Target
MEK1/2 Targets
BRAF V600 Target
HER2 Target
VEGFR-1/2/3 Targets
PD-1 Target
CTLA-4 Target
Global Targeted Drugs for Colorectal Cancer Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeted Drugs for Colorectal Cancer Market Segment Percentages, by Application, 2023 (%)
Hospital
Specialty Clinic
Global Targeted Drugs for Colorectal Cancer Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Targeted Drugs for Colorectal Cancer Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Drugs for Colorectal Cancer revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Targeted Drugs for Colorectal Cancer revenues share in global market, 2023 (%)
Key companies Targeted Drugs for Colorectal Cancer sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Targeted Drugs for Colorectal Cancer sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
Amgen
F. Hoffmann-La Roche Ltd
Novartis
Array BioPharma
Genentech
Bayer
Sanofi
Lilly
Bristol myers squibb
MSD lreland
HUTCHMED
Outline of Major Chapters:
Chapter 1: Introduces the definition of Targeted Drugs for Colorectal Cancer, market overview.
Chapter 2: Global Targeted Drugs for Colorectal Cancer market size in revenue and volume.
Chapter 3: Detailed analysis of Targeted Drugs for Colorectal Cancer manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Targeted Drugs for Colorectal Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Targeted Drugs for Colorectal Cancer capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Targeted Drugs for Colorectal Cancer Market, Global Outlook and Forecast 2024-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2023 |
| Forecast Year |
2031 |
| Number of Pages |
71 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Targeted Drugs for Colorectal Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Drugs for Colorectal Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Drugs for Colorectal Cancer Overall Market Size
2.1 Global Targeted Drugs for Colorectal Cancer Market Size: 2023 VS 2030
2.2 Global Targeted Drugs for Colorectal Cancer Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Targeted Drugs for Colorectal Cancer Sales: 2019-2030
3 Company Landscape
3.1 Top Targeted Drugs for Colorectal Cancer Players in Global Market
3.2 Top Global Targeted Drugs for Colorectal Cancer Companies Ranked by Revenue
3.3 Global Targeted Drugs for Colorectal Cancer Revenue by Companies
3.4 Global Targeted Drugs for Colorectal Cancer Sales by Companies
3.5 Global Targeted Drugs for Colorectal Cancer Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Targeted Drugs for Colorectal Cancer Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Targeted Drugs for Colorectal Cancer Product Type
3.8 Tier 1, Tier 2 and Tier 3 Targeted Drugs for Colorectal Cancer Players in Global Market
3.8.1 List of Global Tier 1 Targeted Drugs for Colorectal Cancer Companies
3.8.2 List of Global Tier 2 and Tier 3 Targeted Drugs for Colorectal Cancer Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Targeted Drugs for Colorectal Cancer Market Size Markets, 2023 & 2030
4.1.2 EGFR Target
4.1.3 BRAF Target
4.1.4 MEK1/2 Targets
4.1.5 BRAF V600 Target
4.1.6 HER2 Target
4.1.7 VEGFR-1/2/3 Targets
4.1.8 PD-1 Target
4.1.9 CTLA-4 Target
4.2 By Type - Global Targeted Drugs for Colorectal Cancer Revenue & Forecasts
4.2.1 By Type - Global Targeted Drugs for Colorectal Cancer Revenue, 2019-2024
4.2.2 By Type - Global Targeted Drugs for Colorectal Cancer Revenue, 2025-2030
4.2.3 By Type - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
4.3 By Type - Global Targeted Drugs for Colorectal Cancer Sales & Forecasts
4.3.1 By Type - Global Targeted Drugs for Colorectal Cancer Sales, 2019-2024
4.3.2 By Type - Global Targeted Drugs for Colorectal Cancer Sales, 2025-2030
4.3.3 By Type - Global Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
4.4 By Type - Global Targeted Drugs for Colorectal Cancer Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Drugs for Colorectal Cancer Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Specialty Clinic
5.2 By Application - Global Targeted Drugs for Colorectal Cancer Revenue & Forecasts
5.2.1 By Application - Global Targeted Drugs for Colorectal Cancer Revenue, 2019-2024
5.2.2 By Application - Global Targeted Drugs for Colorectal Cancer Revenue, 2025-2030
5.2.3 By Application - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
5.3 By Application - Global Targeted Drugs for Colorectal Cancer Sales & Forecasts
5.3.1 By Application - Global Targeted Drugs for Colorectal Cancer Sales, 2019-2024
5.3.2 By Application - Global Targeted Drugs for Colorectal Cancer Sales, 2025-2030
5.3.3 By Application - Global Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
5.4 By Application - Global Targeted Drugs for Colorectal Cancer Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Targeted Drugs for Colorectal Cancer Market Size, 2023 & 2030
6.2 By Region - Global Targeted Drugs for Colorectal Cancer Revenue & Forecasts
6.2.1 By Region - Global Targeted Drugs for Colorectal Cancer Revenue, 2019-2024
6.2.2 By Region - Global Targeted Drugs for Colorectal Cancer Revenue, 2025-2030
6.2.3 By Region - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
6.3 By Region - Global Targeted Drugs for Colorectal Cancer Sales & Forecasts
6.3.1 By Region - Global Targeted Drugs for Colorectal Cancer Sales, 2019-2024
6.3.2 By Region - Global Targeted Drugs for Colorectal Cancer Sales, 2025-2030
6.3.3 By Region - Global Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Targeted Drugs for Colorectal Cancer Revenue, 2019-2030
6.4.2 By Country - North America Targeted Drugs for Colorectal Cancer Sales, 2019-2030
6.4.3 US Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.4.4 Canada Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.4.5 Mexico Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Targeted Drugs for Colorectal Cancer Revenue, 2019-2030
6.5.2 By Country - Europe Targeted Drugs for Colorectal Cancer Sales, 2019-2030
6.5.3 Germany Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5.4 France Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5.5 U.K. Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5.6 Italy Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5.7 Russia Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5.8 Nordic Countries Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.5.9 Benelux Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Targeted Drugs for Colorectal Cancer Revenue, 2019-2030
6.6.2 By Region - Asia Targeted Drugs for Colorectal Cancer Sales, 2019-2030
6.6.3 China Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.6.4 Japan Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.6.5 South Korea Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.6.6 Southeast Asia Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.6.7 India Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Targeted Drugs for Colorectal Cancer Revenue, 2019-2030
6.7.2 By Country - South America Targeted Drugs for Colorectal Cancer Sales, 2019-2030
6.7.3 Brazil Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.7.4 Argentina Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Sales, 2019-2030
6.8.3 Turkey Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.8.4 Israel Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.8.5 Saudi Arabia Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
6.8.6 UAE Targeted Drugs for Colorectal Cancer Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Targeted Drugs for Colorectal Cancer Major Product Offerings
7.1.4 Merck Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.1.5 Merck Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Targeted Drugs for Colorectal Cancer Major Product Offerings
7.2.4 Amgen Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.2.5 Amgen Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Company Summary
7.3.2 F. Hoffmann-La Roche Ltd Business Overview
7.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.3.5 F. Hoffmann-La Roche Ltd Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Targeted Drugs for Colorectal Cancer Major Product Offerings
7.4.4 Novartis Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Array BioPharma
7.5.1 Array BioPharma Company Summary
7.5.2 Array BioPharma Business Overview
7.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Major Product Offerings
7.5.4 Array BioPharma Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.5.5 Array BioPharma Key News & Latest Developments
7.6 Genentech
7.6.1 Genentech Company Summary
7.6.2 Genentech Business Overview
7.6.3 Genentech Targeted Drugs for Colorectal Cancer Major Product Offerings
7.6.4 Genentech Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.6.5 Genentech Key News & Latest Developments
7.7 Bayer
7.7.1 Bayer Company Summary
7.7.2 Bayer Business Overview
7.7.3 Bayer Targeted Drugs for Colorectal Cancer Major Product Offerings
7.7.4 Bayer Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.7.5 Bayer Key News & Latest Developments
7.8 Sanofi
7.8.1 Sanofi Company Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Targeted Drugs for Colorectal Cancer Major Product Offerings
7.8.4 Sanofi Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.8.5 Sanofi Key News & Latest Developments
7.9 Lilly
7.9.1 Lilly Company Summary
7.9.2 Lilly Business Overview
7.9.3 Lilly Targeted Drugs for Colorectal Cancer Major Product Offerings
7.9.4 Lilly Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.9.5 Lilly Key News & Latest Developments
7.10 Bristol myers squibb
7.10.1 Bristol myers squibb Company Summary
7.10.2 Bristol myers squibb Business Overview
7.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Major Product Offerings
7.10.4 Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.10.5 Bristol myers squibb Key News & Latest Developments
7.11 MSD lreland
7.11.1 MSD lreland Company Summary
7.11.2 MSD lreland Targeted Drugs for Colorectal Cancer Business Overview
7.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Major Product Offerings
7.11.4 MSD lreland Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.11.5 MSD lreland Key News & Latest Developments
7.12 HUTCHMED
7.12.1 HUTCHMED Company Summary
7.12.2 HUTCHMED Targeted Drugs for Colorectal Cancer Business Overview
7.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Major Product Offerings
7.12.4 HUTCHMED Targeted Drugs for Colorectal Cancer Sales and Revenue in Global (2019-2024)
7.12.5 HUTCHMED Key News & Latest Developments
8 Global Targeted Drugs for Colorectal Cancer Production Capacity, Analysis
8.1 Global Targeted Drugs for Colorectal Cancer Production Capacity, 2019-2030
8.2 Targeted Drugs for Colorectal Cancer Production Capacity of Key Manufacturers in Global Market
8.3 Global Targeted Drugs for Colorectal Cancer Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Targeted Drugs for Colorectal Cancer Supply Chain Analysis
10.1 Targeted Drugs for Colorectal Cancer Industry Value Chain
10.2 Targeted Drugs for Colorectal Cancer Upstream Market
10.3 Targeted Drugs for Colorectal Cancer Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Targeted Drugs for Colorectal Cancer Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Targeted Drugs for Colorectal Cancer in Global Market
Table 2. Top Targeted Drugs for Colorectal Cancer Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Targeted Drugs for Colorectal Cancer Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Targeted Drugs for Colorectal Cancer Revenue Share by Companies, 2019-2024
Table 5. Global Targeted Drugs for Colorectal Cancer Sales by Companies, (K Units), 2019-2024
Table 6. Global Targeted Drugs for Colorectal Cancer Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Targeted Drugs for Colorectal Cancer Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Targeted Drugs for Colorectal Cancer Product Type
Table 9. List of Global Tier 1 Targeted Drugs for Colorectal Cancer Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Drugs for Colorectal Cancer Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Targeted Drugs for Colorectal Cancer Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Targeted Drugs for Colorectal Cancer Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Targeted Drugs for Colorectal Cancer Sales (K Units), 2019-2024
Table 15. By Type - Global Targeted Drugs for Colorectal Cancer Sales (K Units), 2025-2030
Table 16. By Application ? Global Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Targeted Drugs for Colorectal Cancer Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Targeted Drugs for Colorectal Cancer Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Targeted Drugs for Colorectal Cancer Sales (K Units), 2019-2024
Table 20. By Application - Global Targeted Drugs for Colorectal Cancer Sales (K Units), 2025-2030
Table 21. By Region ? Global Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Targeted Drugs for Colorectal Cancer Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Targeted Drugs for Colorectal Cancer Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Targeted Drugs for Colorectal Cancer Sales (K Units), 2019-2024
Table 25. By Region - Global Targeted Drugs for Colorectal Cancer Sales (K Units), 2025-2030
Table 26. By Country - North America Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Targeted Drugs for Colorectal Cancer Sales, (K Units), 2019-2024
Table 29. By Country - North America Targeted Drugs for Colorectal Cancer Sales, (K Units), 2025-2030
Table 30. By Country - Europe Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Targeted Drugs for Colorectal Cancer Sales, (K Units), 2019-2024
Table 33. By Country - Europe Targeted Drugs for Colorectal Cancer Sales, (K Units), 2025-2030
Table 34. By Region - Asia Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Targeted Drugs for Colorectal Cancer Sales, (K Units), 2019-2024
Table 37. By Region - Asia Targeted Drugs for Colorectal Cancer Sales, (K Units), 2025-2030
Table 38. By Country - South America Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Targeted Drugs for Colorectal Cancer Sales, (K Units), 2019-2024
Table 41. By Country - South America Targeted Drugs for Colorectal Cancer Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Sales, (K Units), 2025-2030
Table 46. Merck Company Summary
Table 47. Merck Targeted Drugs for Colorectal Cancer Product Offerings
Table 48. Merck Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. Merck Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Targeted Drugs for Colorectal Cancer Product Offerings
Table 52. Amgen Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. Amgen Key News & Latest Developments
Table 54. F. Hoffmann-La Roche Ltd Company Summary
Table 55. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product Offerings
Table 56. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. F. Hoffmann-La Roche Ltd Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Targeted Drugs for Colorectal Cancer Product Offerings
Table 60. Novartis Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Array BioPharma Company Summary
Table 63. Array BioPharma Targeted Drugs for Colorectal Cancer Product Offerings
Table 64. Array BioPharma Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Array BioPharma Key News & Latest Developments
Table 66. Genentech Company Summary
Table 67. Genentech Targeted Drugs for Colorectal Cancer Product Offerings
Table 68. Genentech Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Genentech Key News & Latest Developments
Table 70. Bayer Company Summary
Table 71. Bayer Targeted Drugs for Colorectal Cancer Product Offerings
Table 72. Bayer Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Bayer Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Targeted Drugs for Colorectal Cancer Product Offerings
Table 76. Sanofi Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Sanofi Key News & Latest Developments
Table 78. Lilly Company Summary
Table 79. Lilly Targeted Drugs for Colorectal Cancer Product Offerings
Table 80. Lilly Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Lilly Key News & Latest Developments
Table 82. Bristol myers squibb Company Summary
Table 83. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product Offerings
Table 84. Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Bristol myers squibb Key News & Latest Developments
Table 86. MSD lreland Company Summary
Table 87. MSD lreland Targeted Drugs for Colorectal Cancer Product Offerings
Table 88. MSD lreland Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. MSD lreland Key News & Latest Developments
Table 90. HUTCHMED Company Summary
Table 91. HUTCHMED Targeted Drugs for Colorectal Cancer Product Offerings
Table 92. HUTCHMED Targeted Drugs for Colorectal Cancer Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. HUTCHMED Key News & Latest Developments
Table 94. Targeted Drugs for Colorectal Cancer Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 95. Global Targeted Drugs for Colorectal Cancer Capacity Market Share of Key Manufacturers, 2021-2024
Table 96. Global Targeted Drugs for Colorectal Cancer Production by Region, 2019-2024 (K Units)
Table 97. Global Targeted Drugs for Colorectal Cancer Production by Region, 2025-2030 (K Units)
Table 98. Targeted Drugs for Colorectal Cancer Market Opportunities & Trends in Global Market
Table 99. Targeted Drugs for Colorectal Cancer Market Drivers in Global Market
Table 100. Targeted Drugs for Colorectal Cancer Market Restraints in Global Market
Table 101. Targeted Drugs for Colorectal Cancer Raw Materials
Table 102. Targeted Drugs for Colorectal Cancer Raw Materials Suppliers in Global Market
Table 103. Typical Targeted Drugs for Colorectal Cancer Downstream
Table 104. Targeted Drugs for Colorectal Cancer Downstream Clients in Global Market
Table 105. Targeted Drugs for Colorectal Cancer Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Targeted Drugs for Colorectal Cancer Segment by Type in 2023
Figure 2. Targeted Drugs for Colorectal Cancer Segment by Application in 2023
Figure 3. Global Targeted Drugs for Colorectal Cancer Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Targeted Drugs for Colorectal Cancer Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Targeted Drugs for Colorectal Cancer Revenue, 2019-2030 (US$, Mn)
Figure 7. Targeted Drugs for Colorectal Cancer Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Targeted Drugs for Colorectal Cancer Revenue in 2023
Figure 9. By Type - Global Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 11. By Type - Global Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 12. By Type - Global Targeted Drugs for Colorectal Cancer Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 15. By Application - Global Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 16. By Application - Global Targeted Drugs for Colorectal Cancer Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 20. By Region - Global Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 21. By Country - North America Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 22. By Country - North America Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 23. US Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 28. Germany Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 29. France Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 37. China Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 41. India Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 43. By Country - South America Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 44. Brazil Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Targeted Drugs for Colorectal Cancer Sales Market Share, 2019-2030
Figure 48. Turkey Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Targeted Drugs for Colorectal Cancer Revenue, (US$, Mn), 2019-2030
Figure 52. Global Targeted Drugs for Colorectal Cancer Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Targeted Drugs for Colorectal Cancer by Region, 2023 VS 2030
Figure 54. Targeted Drugs for Colorectal Cancer Industry Value Chain
Figure 55. Marketing Channels
